stockrow
Friday 6 November 2026
Export EMBC’s income statement to Excel — free account
Embecta Corp.
EMBC Healthcare Medical Instruments & Supplies
Embecta Corp.’s revenue for fiscal 2025 (year ended September 2025) was $1.1 billion, down 3.80% from fiscal 2024.
- Revenue
- −8.05%
- EPS
- −53.9%
- Free cash flow
- −49.6%
- Total debt
- −1.00%
Quarter to June 2026, against a year earlier
6.19
0.14
−2.21%
Follow EMBC
Alert me
Embecta Corp. (EMBC) P/E ratio
As of 5 November 2026, Embecta Corp. (EMBC) trades at a P/E ratio of 4.2×. Over the past ten years it has ranged from 1.5× (May 2026) to 26.7× (August 2023); the current reading is higher than 23% of that period. That is below the Medical Instruments & Supplies industry median of 30.3× and below the Healthcare sector median of 25.2×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 8.7× | (17.12%) |
| FY2024 | 10.4× | (12.55%) |
| FY2023 | 11.9× | 61.38% |
| FY2022 | 7.4× | 41.85% |
| FY2021 | 5.2× | 0.00% |
| FY2021 | 5.2× | 0.00% |
| FY2020 | 5.2× | 0.00% |
| FY2020 | 5.2× | 0.00% |
| FY2019 | 5.2× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 2.2× | (52.73%) |
| Mar 2026 | 4.6× | (7.28%) |
| Dec 2025 | 5.0× | (42.34%) |
| Sep 2025 | 8.7× | 27.75% |
| 19 more quarters | Free account |
Against its own ten years
Low 1.5×
High 26.7×
Ten-year median
10.0×
Current reading's percentile
23
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| SMTI Sanara MedTech Inc. compare | n/m |
| KRMD KORU Medical Systems, Inc. compare | n/m |
| ANGO AngioDynamics, Inc. compare | n/m |
| OSUR OraSure Technologies, Inc. compare | n/m |
| EMBC Embecta Corp. | 4.2× |
| PDEX Pro-Dex, Inc. compare | 16.4× |
| UTMD Utah Medical Products, Inc. compare | 21.7× |
| NNNN Anbio Biotechnology compare | — |
| ZJYL Jin Medical International Ltd. compare | — |
| Medical Instruments & Supplies industry median | 30.3× |
| Healthcare sector median | 25.2× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)